v3.26.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash in the balance sheets that sum to the total of the same such amounts shown in the statements of cash flows (in thousands):
March 31,
2026		December 31,
2025
Cash and cash equivalents$124,161 $103,845 
Restricted cash339 339 
Total cash, cash equivalents and restricted cash$124,500 $104,184 
Schedule of Restrictions on Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash in the balance sheets that sum to the total of the same such amounts shown in the statements of cash flows (in thousands):
March 31,
2026		December 31,
2025
Cash and cash equivalents$124,161 $103,845 
Restricted cash339 339 
Total cash, cash equivalents and restricted cash$124,500 $104,184 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following potentially dilutive securities have been excluded from the diluted per share calculations as they would be anti-dilutive:
Three Months Ended March 31,
20262025
Outstanding stock options2,820,0382,086,334
Restricted stock units296,578279,458
Performance stock units252,124252,124
Shares issuable under 2023 Employee Stock Purchase Plan3,942—
Total3,372,6822,617,916